Kozak & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.23K | Hold |
13
| – | – | ﹤0.01% | 274 |
|
|
2025
Q1 | $6.45K | Hold |
13
| – | – | ﹤0.01% | 259 |
|
|
2024
Q4 | $5.29K | Hold |
13
| – | – | ﹤0.01% | 290 |
|
|
2024
Q3 | $6.33K | Hold |
13
| – | – | ﹤0.01% | 261 |
|
|
2024
Q2 | $6.11K | Hold |
13
| – | – | ﹤0.01% | 257 |
|
|
2024
Q1 | $5.73K | Hold |
13
| – | – | ﹤0.01% | 268 |
|
|
2023
Q4 | $5.69K | Hold |
13
| – | – | ﹤0.01% | 267 |
|
|
2023
Q3 | $4.69K | Hold |
13
| – | – | ﹤0.01% | 290 |
|
|
2023
Q2 | $4.52K | Hold |
13
| – | – | ﹤0.01% | 278 |
|
|
2023
Q1 | $4.1K | Hold |
13
| – | – | ﹤0.01% | 278 |
|
|
2022
Q4 | $4K | Hold |
13
| – | – | ﹤0.01% | 280 |
|
|
2022
Q3 | $4K | Hold |
13
| – | – | ﹤0.01% | 277 |
|
|
2022
Q2 | $4K | Hold |
13
| – | – | ﹤0.01% | 312 |
|
|
2022
Q1 | $3K | Hold |
13
| – | – | ﹤0.01% | 345 |
|
|
2021
Q4 | $3K | Hold |
13
| – | – | ﹤0.01% | 345 |
|
|
2021
Q3 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 312 |
|